If you're working with lipid-based formulations or exploring strategies to improve oral drug delivery, I'd like to invite you to join us for an in-person seminar in San Francisco on October 8th. This session brings together formulation scientists, preclinical experts, and innovation leaders to discuss practical strategies that bridge discovery and development, including the use of artificial intelligence.
Agenda Highlights:
- SEDDS for enhanced oral bioavailability – from concept to creation
- In vivo dosing considerations for preclinical and clinical studies
- Unlocking the potential of lipid excipients in oral solid dosage forms
- Pediatric formulations & life cycle management strategies with SEDDS
- AI-driven SEDDS development – accelerating screening & optimization
- Stability & oxidation management for robust formulations
Featured Speakers:
- Christine Allen, PhD: Professor at University of Toronto and Co-Founder/CEO of Intrepid Labs
- Inayet Ellis, PhD: Scientific Affairs Director, Gattefossé USA
- Masumi Dave, PHD: Application Lab Manager, Gattefossé USA
- Nick DiFranco, MEM: Senior Marketing Manager, Gattefossé USA
- Lissette Perez: Technical Sales Representative, Gattefossé USA
The day will also include networking breaks, lunch, and opportunities to connect with peers who share an interest in advancing lipid-based drug delivery science.
📍 Location: DoubleTree by Hilton Hotel Newark-Fremont, 39900 Balentine Drive, Newark, CA
📅 Date: October 8, 2025 | 8:30 AM - 3:40 PM
👉 Registration is free of charge, subject to confirmation
Register here: https://forms.office.com/e/gebK9fkbr8
------------------------------
Masumi Dave
Lab Manager
Gattefosse Corporation
Paramus NJ
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------